Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cancer Chemother Pharmacol ; 44(2): 164-9, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10412952

RESUMEN

PURPOSE: To examine the histopathology of the kidney in mice following repeated injections of the antitumor drug onconase, and to determine whether lysine, which reportedly blocks kidney uptake of other basic proteins, blocks the high renal uptake of onconase. METHODS: Mice received repeated intraperitoneal onconase injections over 3 weeks. Kidneys were examined by light microscopy after 1 week, 3 weeks, and 5 weeks (2 weeks after cessation of injections) and compared to kidneys from animals receiving a similar schedule of PBS injections. Renal uptake of radioiodinated onconase was measured in animals receiving intraperitoneal injections of lysine solutions of acidic and neutral pH given at -30, 0 and + 5 min relative to intravenous onconase injection. Renal onconase uptake was also measured in animals made metabolically acidotic by ingestion of ammonium chloride, arginine chloride or lysine dihydrochloride from the drinking water. RESULTS: Onconase caused acute moderate multifocal proximal renal tubular necrosis, and this toxicity was reversed by 2 weeks after drug withdrawal. Intraperitoneal injections of lysine dihydrochloride in PBS (pH 1.5) reduced renal onconase uptake at 15 min from 67.9+/-13.4% to 17.0+/-3.8% of the injected dose without affecting the plasma concentration and also reduced the fraction of degraded onconase in the urine. However, neutral solutions of lysine dihydrochloride at pH 7.4 or lysine acetate at pH 7.1 were ineffective at blocking renal onconase uptake. Furthermore, renal onconase uptake was minimally or not affected by a state of metabolic acidosis. CONCLUSIONS: Proximal tubular toxicity of onconase was reversible. Renal onconase uptake was blocked by lysine at pH 1.5 but not at neutral pH.


Asunto(s)
Antineoplásicos/toxicidad , Proteínas del Huevo/toxicidad , Riñón/efectos de los fármacos , Lisina/farmacología , Ribonucleasas/toxicidad , Acidosis/metabolismo , Animales , Proteínas del Huevo/farmacocinética , Femenino , Concentración de Iones de Hidrógeno , Riñón/metabolismo , Riñón/patología , Ratones , Ratones Endogámicos BALB C , Ribonucleasas/farmacocinética
3.
Chem Res Toxicol ; 6(5): 609-15, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8292737

RESUMEN

Immunoblotting studies have previously shown that serum antibodies from halothane hepatitis patients react with several liver microsomal proteins that have been modified by the trifluoroacetyl halide metabolite of halothane. In this study, an 80-kDa protein recognized by the patients' antibodies has been purified from rat liver microsomes and characterized. When the purified trifluoroacetylated 80-kDa and native 80-kDa proteins were employed as test antigens in an enzyme-linked immunosorbent assay, serum antibodies from halothane hepatitis patients reacted with both of these proteins to a significantly greater extent than did serum antibodies from control patients. Amino acid sequence analyses of several hydrolytic peptide fragments of the 80-kDa protein showed that the protein was 99% identical to the deduced amino acid sequence of a murine cDNA of the luminal endoplasmic reticulum protein ERp72. These results indicate that trifluoroacetylated ERp72 in the liver of halothane hepatitis patients may induce immune responses against epitopes present on the covalently altered protein and those present on the native protein and may have a role in halothane hepatitis. In addition, immunoblot and immunohistochemical studies revealed that the 80-kDa protein was present in all tissues studied, but was in highest concentration in liver, adipose tissue, ovaries, and testes and was enriched in specific cells of some organs. In the future, these findings should help define the physiological function of ERp72.


Asunto(s)
Anticuerpos/inmunología , Enfermedad Hepática Inducida por Sustancias y Drogas/inmunología , Retículo Endoplásmico/metabolismo , Halotano/toxicidad , Glicoproteínas de Membrana/inmunología , Secuencia de Aminoácidos , Animales , Ensayo de Inmunoadsorción Enzimática , Humanos , Immunoblotting , Inmunohistoquímica , Masculino , Microsomas Hepáticos/química , Microsomas Hepáticos/inmunología , Datos de Secuencia Molecular , Ratas , Ratas Sprague-Dawley , Ácido Trifluoroacético/química
4.
Infect Immun ; 61(8): 3392-402, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8335369

RESUMEN

In earlier studies using a streptomycin-treated mouse model of infection caused by enterohemorrhagic Escherichia coli (EHEC), animals fed Shiga-like toxin type II (SLT-II)-producing strains developed acute renal cortical necrosis and died, while mice fed Shiga-like toxin type I (SLT-I)-producing clones did not die (E. A. Wadolkowski, L. M. Sung, J. A. Burris, J. E. Samuel, and A. D. O'Brien, Infect. Immun. 58:3959-3965, 1990). To examine the bases for the differences we noted between the two toxins in the murine infection model, we injected mice with purified toxins and carried out histopathological examinations. Despite the genetic and structural similarities between the two toxins, SLT-II had a 50% lethal dose (LD50) which was approximately 400 times lower than that of SLT-I when injected intravenously or intraperitoneally into mice. Histopathologic examination of toxin-injected mice revealed that detectable damage was limited to renal cortical tubule epithelial cells. Passive administration of anti-SLT-II antibodies protected mice from SLT-II-mediated kidney damage and death. Immunofluorescence staining of normal murine kidney sections incubated with purified SLT-I or SLT-II demonstrated that both toxins bound to cortical tubule and medullary duct epithelial cells. Compared with SLT-I, SLT-II was more heat and pH stable, suggesting that SLT-II is a relatively more stable macromolecule. Although both toxins bound to globotriaosylceramide, SLT-I bound with a higher affinity in a solid-phase binding assay. Differences in enzymatic activity between the two toxins were not detected. These data suggest that structural/functional differences between the two toxins, possibly involving holotoxin stability and/or receptor affinity, may contribute to the differential LD50s in mice.


Asunto(s)
Toxinas Bacterianas/toxicidad , Enterotoxinas/toxicidad , Escherichia coli/patogenicidad , Animales , Anticuerpos Monoclonales/inmunología , Toxinas Bacterianas/inmunología , Toxinas Bacterianas/metabolismo , Calor , Concentración de Iones de Hidrógeno , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón/patología , Dosificación Letal Mediana , Masculino , Ratones , Toxina Shiga I , Toxina Shiga II , Trihexosilceramidas/análisis , Trihexosilceramidas/metabolismo
5.
J Immunol ; 147(3): 1014-22, 1991 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-1677668

RESUMEN

Cryptosporidium is a protozoan parasite that can cause chronic life-threatening diarrhea in immunocompromised persons. Host immune responses are poorly understood, an impediment to development of effective therapy. In mice, normal adult BALB/c animals resist infection whereas chronic symptomatic cryptosporidiosis develops in adult nude mice and in neonatally infected BALB/c mice treated with anti-CD4 mAb. To define further the immune defects that allow mice to be infected with Cryptosporidium, adult BALB/c mice were treated with cytolytic anti-CD4 or anti-CD8 or with neutralizing anti-IFN-gamma or anti-IL-2 mAb. Chronic infection, manifested by continuous shedding of sparse but statistically significant numbers of oocysts, occurred with anti-CD4 +/- anti-CD8 mAb treatment although anti-CD8 mAb treatment alone did not allow infection. Treatment with anti-IFN-gamma mAb greatly enhanced oocyst shedding but infection was self-limited. Treatment with a combination of anti-CD4 and anti-IFN-gamma mAb permitted both chronic infection and shedding of large numbers of oocysts. Furthermore mice treated initially with anti-CD4 mAb showed a substantial increase in oocyst shedding when later treated with anti-IFN-gamma mAb; and mice treated initially with both mAbs showed a decline in oocyst shedding when anti-IFN-gamma mAb was stopped. Anti-IFN-gamma mAb treatment of congenitally athymic adult BALB/c mice led to an approximately a 75-fold increase in oocyst shedding. Treatment of adult BALB/c mice with anti-IL-2 mAb did not permit Cryptosporidium infection. These results suggest that redundant immunologic mechanisms limit Cryptosporidium infection such that both CD4+ cells and IFN-gamma are required to prevent initiation of infection whereas either alone can limit the extent (IFN-gamma) or duration (CD4+ T cells) of infection. They also suggest that production of IFN-gamma by a non-T cell contributes to host immunity.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Criptosporidiosis/inmunología , Interferón gamma/inmunología , Análisis de Varianza , Animales , Anticuerpos Monoclonales , Antígenos de Diferenciación de Linfocitos T/fisiología , Antígenos CD4/fisiología , Antígenos CD8 , Modelos Animales de Enfermedad , Heces/microbiología , Íleon/patología , Inmunidad Innata , Depleción Linfocítica , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Factores de Tiempo
6.
J Cereb Blood Flow Metab ; 11(1): 88-98, 1991 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1984008

RESUMEN

To study the causes of spatial and temporal evolution of progressive neuro-injury in focal brain ischemia, models with consistent lesion topography are required. In such models, continuous monitoring of the microcirculation in a penumbral area undergoing progressive damage could be possible. We used a fixed-pulse (1.0 s, 40 W) Nd-YAG laser (NYL) to produced discrete brain lesions in rats and monitored the cerebral blood flow (CBF) with laser-Doppler flowmetry (LDF) in nonirradiated areas directly adjacent to the maturing lesion. We also examined the time evolution of the lesion topography over a 4 day period. The lesion volume determined by histopathological methods increased from 3.1 +/- 0.5 to 4.5 +/- 0.5 mm3 (p less than 0.05) during the first 2 h. Simultaneously, LDF indicated severe hypoperfusion (-60 +/- 21%, p less than 0.01) at a zone (1 mm distance from the laser lesion) where progressive neuronal degeneration and increased tissue water content (80.0 +/- 3.3% versus 76.8 +/- 2.1% in normal tissue, n = 7, p less than 0.05) were also observed. At a 4 mm distance from the lesion, hyperemic CBF responses were observed, but no histopathological signs or edema. Secondary brain damage progressed up to 4 days (lesion volume of 6.0 +/- 0.7 mm3). The NYL-induced brain lesion produced a highly reproducible focal injury and progressive neuronal death in a spatial relationship with microcirculatory failure and edema formation. The model allows prospective study of tissue state at a discrete zone, which is separate from the initial injury, but susceptible to secondary brain damage.


Asunto(s)
Encefalopatías/etiología , Isquemia Encefálica/complicaciones , Corteza Cerebral/irrigación sanguínea , Modelos Animales de Enfermedad , Rayos Láser , Microcirculación/fisiopatología , Animales , Encéfalo/patología , Encefalopatías/patología , Encefalopatías/fisiopatología , Edema Encefálico , Isquemia Encefálica/etiología , Corteza Cerebral/patología , Masculino , Neuronas/patología , Ratas , Ratas Endogámicas
7.
Infect Immun ; 58(12): 3959-65, 1990 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2254023

RESUMEN

Escherichia coli O157:H7 strains have been implicated as etiologic agents in food-borne outbreaks of hemorrhagic colitis and the hemolytic-uremic syndrome. A prototype E. coli O157:H7 strain, designated 933, produces Shiga-like toxin I (SLT-I) and SLT-II and harbors a 60-MDa plasmid. In a previous study, streptomycin-treated mice were fed 933 together with a derivative cured of the 60-MDa plasmid (designated 933cu). Strain 933cu colonized poorly, but in approximately one-third of the animals, an isolate of 933cu was obtained from the feces that had regained the ability to colonize well. This isolate, designated 933cu-rev, killed all of the animals when fed alone to mice. In this investigation, two types of experiments were done to assess whether SLT-I, SLT-II, or both contributed to the death of mice fed 933cu-rev. (i) Mice were pretreated with monoclonal antibodies to SLT-I, SLT-II, SLT-I and SLT-II, or cholera toxin (as a control) before infection with 933cu-rev. (ii) Mice were fed either an E. coli K-12 strain carrying cloned SLT-I genes or the same K-12 strain carrying cloned SLT-II genes. The results of both types of experiments indicated that the deaths of the orally infected mice were due solely to SLT-II. Extensive histological and selected electron microscopic examinations of various tissues from the infected animals suggested that death was due to acute renal cortical tubular necrosis consistent with toxic renal damage. These data indicate a critical role for SLT-II, but not SLT-I, in renal damage associated with E. coli O157:H7 infection of streptomycin-treated mice.


Asunto(s)
Toxinas Bacterianas/toxicidad , Escherichia coli/metabolismo , Necrosis Tubular Aguda/etiología , Animales , Anticuerpos Monoclonales/inmunología , Toxinas Bacterianas/genética , Toxinas Bacterianas/metabolismo , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/complicaciones , Infecciones por Escherichia coli/patología , Glucolípidos/metabolismo , Hierro/fisiología , Riñón/patología , Riñón/ultraestructura , Ratones , Toxina Shiga II , Estreptomicina/farmacología
8.
Infect Immun ; 58(8): 2438-45, 1990 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2196227

RESUMEN

Enterohemorrhagic Escherichia coli O157:H7 isolates produce Shiga-like toxins and carry a 60-megadalton plasmid which encodes an adhesin for Henle 407 intestinal cells. A streptomycin-treated mouse model was used to compare the intestinal colonizing capacity of E. coli O157:H7 strain 933 with that of its 60-megadalton plasmid-cured derivative, strain 933cu. When fed individually to mice, both 933 and 933cu maintained a stable number of organisms per gram of feces, and the greatest numbers of 933 or 933cu were isolated from cecal and proximal colonic epithelial cells. When 933 and 933cu were simultaneously fed to mice, 933cu was unable to maintain a stable level of colonization in about two-thirds of the mice tested. However, in one-third of the mice, the number of 933cu in feces began to increase rapidly until a stable level of co-colonization with 933 was attained. The isolate from these mice, 933cu-rev, was excreted in high numbers when fed alone to mice and was found on epithelial cells throughout the entire large bowel and distal small intestine. Moreover, 933cu-rev grew in mucus from all segments of the intestine and at higher levels than strain 933 or 933cu. Only mice fed strain 933cu-rev died. Histopathological studies confirmed that mice fed 933cu-rev died from bilateral renal cortical tubular necrosis consistent with toxic insult, perhaps due to Shiga-like toxins. The virulence of 933cu-rev may reflect its ability to grow well in mucus and colonize the small as well as large bowel.


Asunto(s)
Infecciones por Escherichia coli/microbiología , Escherichia coli/patogenicidad , Plásmidos , Animales , Proteínas de la Membrana Bacteriana Externa/administración & dosificación , Proteínas de la Membrana Bacteriana Externa/genética , Modelos Animales de Enfermedad , Escherichia coli/genética , Escherichia coli/crecimiento & desarrollo , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/mortalidad , Infecciones por Escherichia coli/patología , Intestino Grueso/microbiología , Intestino Delgado/microbiología , Necrosis Tubular Aguda/patología , Masculino , Ratones , Moco/microbiología , Especificidad de la Especie , Estreptomicina/administración & dosificación , Virulencia/genética
9.
Radiology ; 176(1): 129-33, 1990 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2191362

RESUMEN

The authors evaluated the safety of ultrasound (US)-guided percutaneous ablation of liver tissue using a neodymium-yttrium-aluminum-garnet (Nd:YAG) laser fiber placed through a skinny needle. The US appearance of the lesion was correlated with the pathologic findings in 19 pigs killed at 1-7 weeks. A 20-gauge needle was percutaneously placed in the liver, and a fiber with a 0.5-cm cladding-stripped tip was inserted. The Nd:YAG laser was fired for 6 minutes at 1-4 W. The early sonographic appearance was recorded, and the US appearance before the pigs were killed was correlated with the gross and histopathologic findings. There were no cases of abdominal bleeding or infection. Mild transient changes in liver function were seen. An initial strong echogenic focus decreased slightly in echogenicity for 10 minutes and then stabilized. Over 1-7 weeks, the 1-cm-diameter lesion decreased in size and developed an echogenic rim that correlated with a peripheral zone of inflammatory repair around a small central cavity and zone of necrosis. US-guided laser ablation of liver tissue is safe in this pig model, and the US appearance corresponds to a process of repair and removal of necrotic liver tissue.


Asunto(s)
Terapia por Láser/métodos , Hígado/cirugía , Ultrasonografía , Animales , Hígado/patología , Porcinos
10.
Infect Immun ; 58(4): 961-9, 1990 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2108092

RESUMEN

Cryptosporidium sp. causes fulminant diarrhea and chronic infection in immunocompromised, particularly human immunodeficiency virus-infected, persons. The lack of in vitro cultivation and a suitable animal model has limited development of effective treatment. We describe two new mouse models of chronic symptomatic cryptosporidiosis in adult athymic mice and in T-cell subset-depleted mice. A progressive infection, fatal within 4 months, occurred in most adult athymic mice; a few developed stable infections. Symptoms included dehydration, weight loss, intermittent diarrhea, and jaundice. Pathologic abnormalities and organisms localized in the intestine in stable infections but involved the hepatobiliary tree and pancreas in others. Lymphoid cells from histocompatible, Cryptosporidium sp.-immune mice cured infected nude mice. Identical infections occurred in neonatally infected BALB/c mice treated with anti-CD4 monoclonal antibodies alone or also with anti-CD8 monoclonal antibodies; the mice were cured when the monoclonal antibody treatments were stopped. These models will be useful in definition of the immune defects that permit chronic cryptosporidiosis to develop and in assessment of treatment modalities.


Asunto(s)
Criptosporidiosis/inmunología , Modelos Animales de Enfermedad , Animales , Anticuerpos Monoclonales/inmunología , Antígenos de Diferenciación de Linfocitos T/inmunología , Antígenos CD4/inmunología , Antígenos CD8 , Enfermedad Crónica , Criptosporidiosis/patología , Femenino , Terapia de Inmunosupresión , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Embarazo , Linfocitos T/inmunología
11.
Radiology ; 174(3 Pt 2): 1021-5, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2305083

RESUMEN

The purpose of this project was to develop an animal model for a fluoroscopically guided application of the contact neodymium-yttrium aluminum garnet (Nd-YAG) laser in the bile duct and identify the factors affecting the extent of damage to the duct wall. This model permits cholangiographic visualization of the duct during laser application. Laser damage is limited by using contact probes and firing the laser while slowly pulling the probe proximally into the duct. Sixteen common bile duct laser burns were produced in 14 dogs. Power settings of 8-25 W were used. The tension of the contact probe along the duct wall, termed "wall tension," was varied through intraoperative manipulation in order to mimic a variety of ductal geometries that might be encountered in clinical use. The authors produced duct damage ranging from a superficial burn to perforation. Power and wall tension were the most important factors in determining the depth and circumference of damage, and the use of 15 W or less did not perforate the duct.


Asunto(s)
Conductos Biliares/cirugía , Fluoroscopía , Terapia por Láser/instrumentación , Animales , Conductos Biliares/patología , Colangiografía , Perros , Fluoroscopía/instrumentación , Fluoroscopía/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA